Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


International News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Device experts set sights on GHTF: European Commission's Medical Devices Experts Group will discuss the preparation of the EC's 2004-2006 Global Harmonization Task Force chairmanship during Oct. 27-28 Brussels meeting. Eucomed Director General Maurice Wagner will serve as vice-chairman (1"The Gray Sheet" June 30, 2003, p. 9). Also on the agenda are reclassification of total joint implants and reports from Study Group 2, which specializes in adverse event reporting. During SG2's Aug. 27-28 meeting, Chair Carol Herman updated the progress of an adverse event coding tool and a proposal to consolidate all adverse event reporting documents for manufacturers...

You may also be interested in...

International News In Brief

EC considers cost of innovation: EU Health Commissioner David Byrne quashes parliamentary inquiry from MEP Camilo Nogueira Roman (Greens-Spain) on the "right to health" in EU citizens' health rights charter. Adopted by stakeholders last November, the charter contends that individuals should have the right to innovative procedures independent of economic considerations. On June 11, Byrne indicated that the EC Treaty delegates medical care delivery to member states, effectively ending the initiative at the European level. Trade associations will now focus on individual countries...

AAM Welcomes Proposal To Update Medicare Part D

After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.

Dr Reddy’s Wants To Break Into Top Five In India

Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts